Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.

30 Aug 2012

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the restorative effects of healthy sleep.

29 Aug 2012

New method simplifies pharmaceutical production of proteins

Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration.

29 Aug 2012

BMBF awards 16M€ to support German epigenome program initiative

The German Ministry for Research and Education (BMBF) will support the German epigenome program initiative "DEEP" with a budget of 16M€ over 5 years.

29 Aug 2012

Edge CT now available in NYU Langone's Department of Radiology clinical practice

NYU Langone Medical Center is the first in the country to offer patients access to the new Siemens Somatom Definition Edge single-source computed tomography system (Edge CT), one of the world's fastest CT scanners capable of generating high quality, 3-D diagnostic images using extremely low radiation.

28 Aug 2012

Community-based pharmacists could provide added resource in identifying knee OA

Canadian researchers have determined that community-based pharmacists could provide an added resource in identifying knee osteoarthritis (OA). The study, published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), represents the first evidence supporting a collaborative approach to managing knee OA.

28 Aug 2012

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2 clinical trial of ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6), in Crohn's disease.

28 Aug 2012

Adult surgery rescues overcorrected club foot deformity

Study findings support the use of supramalleolar osteotomy for patients with hindfoot valgus or subtalar joint deformity following an overcorrected clubfoot.

23 Aug 2012

Women with heart attack symptoms receive lower quality of care than men

A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.

23 Aug 2012

UNH faculty member to study effectiveness of two distinct strength-training regimens on older adults

A University of New Hampshire faculty member has received a grant of more than $360,000 from the National Institutes of Health to study the effectiveness of two distinct strength-training regimens on older adults. The study will compare traditional resistance training exercises, in which participants build muscle strength by lifting heavy weights, to an innovative program that uses very light resistance coupled with blood flow restriction.

23 Aug 2012

Study quantifies discrepancies between physicians and patients with rheumatoid arthritis

For people suffering from rheumatoid arthritis, pain is the crucial factor in their personal perception of the condition. The doctors treating them, however, assess the severity of the disease based on the swelling of the joints. This discrepancy often leads to conflict between patients and their physicians, as a study by Daniel Aletaha and Paul Studenic from the University Department of Internal Medicine III at the MedUni Vienna has now revealed in more detail for the first time.

23 Aug 2012

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

New research from SRI International finds that mosquitoes commonly found in the United States can be infected with a disease-causing virus from Asia. The research findings are from a recent study that modeled how mosquito-borne infections can become introduced.

23 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development.

22 Aug 2012

FDA extends action date for Pfizer’s tofacitinib NDA review

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application (NDA) for tofacitinib, an investigational oral treatment for adults with moderately to severely active rheumatoid arthritis (RA).

22 Aug 2012

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

22 Aug 2012

GM-CSF depletion suppresses pain in people with arthritis-related conditions

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.

22 Aug 2012

Stem-cell therapy holds promise for postinjury arthritis prevention

A novel stem-cell treatment may hold the key to treating osteoarthritis triggered by joint injury, suggest results from an animal study.

21 Aug 2012

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

New method simplifies pharmaceutical production of proteins

BMBF awards 16M€ to support German epigenome program initiative

Edge CT now available in NYU Langone's Department of Radiology clinical practice

Community-based pharmacists could provide added resource in identifying knee OA

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Adult surgery rescues overcorrected club foot deformity

Women with heart attack symptoms receive lower quality of care than men

UNH faculty member to study effectiveness of two distinct strength-training regimens on older adults

Study quantifies discrepancies between physicians and patients with rheumatoid arthritis

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

FDA warns consumers about potential health risks of two natural dietary supplements

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

FDA extends action date for Pfizer’s tofacitinib NDA review

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

GM-CSF depletion suppresses pain in people with arthritis-related conditions

Stem-cell therapy holds promise for postinjury arthritis prevention

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in